New service fees to rise

The government plans to impose new screening service charges to screen the approval of new drugs beforehand, the Korea Food and Drug Administration said Monday.

Under the plan, the service fee for review of safety and efficacy of new drugs is set at 1.79 million won. Others charges for drug approval ranges from 95,000 won to 1.8 million won, which can be reduced by 10 percent in case of onli...